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Abstract
Kidney tubular cell death induced by transforming growth factor-β1 (TGF-β1) is known to contribute to diabetic
nephropathy, a major complication of diabetes. Caspase-3-dependent apoptosis and caspase-1-dependent pyroptosis
are also involved in tubular cell death under diabetic conditions. Recently, ferroptosis, an atypical form of iron-
dependent cell death, was reported to cause kidney disease, including acute kidney injury. Ferroptosis is primed by
lipid peroxide accumulation through the cystine/glutamate antiporter system Xc
− (xCT) and glutathione peroxidase 4
(GPX4)-dependent mechanisms. The aim of this study was to evaluate the role of ferroptosis in diabetes-induced
tubular injury. TGF-β1-stimulated proximal tubular epithelial cells and diabetic mice models were used for in vitro and
in vivo experiments, respectively. xCT and GPX4 expression, cell viability, glutathione concentration, and lipid
peroxidation were quantified to indicate ferroptosis. The effect of ferroptosis inhibition was also assessed. In kidney
biopsy samples from diabetic patients, xCT and GPX4 mRNA expression was decreased compared to nondiabetic
samples. In TGF-β1-stimulated tubular cells, intracellular glutathione concentration was reduced and lipid peroxidation
was enhanced, both of which are related to ferroptosis-related cell death. Ferrostatin-1 (Fer-1), a ferroptosis inhibitor,
alleviated TGF-β1-induced ferroptosis. In diabetic mice, kidney mRNA and protein expressions of xCT and GPX4 were
reduced compared to control. Kidney glutathione concentration was decreased, while lipid peroxidation was
increased in these mice, and these changes were alleviated by Fer-1 treatment. Ferroptosis is involved in kidney
tubular cell death under diabetic conditions. Ferroptosis inhibition could be a therapeutic option for diabetic
nephropathy.
Introduction
Diabetic nephropathy, a severe microvascular compli-
cation of diabetes, is characterized by proteinuria and a
progressive decline in kidney function, leading to end-
stage kidney disease1,2. The pathological features of dia-
betic nephropathy include extracellular matrix (ECM)
accumulation within the glomeruli and tubulointerstitium
and glomerular and tubular cell death, all of which con-
tribute to the development of kidney fibrosis and tubular
atrophy3–5. Accumulating evidence indicates that high
glucose, hemodynamic changes, and local growth factors
are all involved in the pathogenesis of diabetic nephro-
pathy6–10. In particular, transforming growth factor-β
(TGF-β) is regarded as one of the main mediators of the
deleterious effects of the diabetic milieu, and is known to
mediate kidney fibrosis and tubular cell death under
diabetic conditions11–13. Meanwhile, a number of pre-
vious studies have shown that caspase-3-dependent
apoptosis and caspase-1-dependent pyroptosis are also
involved in tubular cell death in diabetic nephropathy14,15.
A new atypical form of cell death, ferroptosis, was
recently identified. Ferroptosis, iron-dependent cell death,
is different from apoptosis, pyroptosis, and receptor-
interacting protein kinase-dependent necroptosis16. The
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key mediators of ferroptosis are cystine/glutamate anti-
porter system Xc
− (xCT) and glutathione peroxidase 4
(GPX4), an antioxidant enzyme. Low xCT and GPX4
levels reduce intracellular cystine concentrations, which
in turn diminish glutathione synthesis, and lipid peroxide
degradation, respectively. Both of these changes result in
the accumulation of intracellular lipid peroxide, which
leads to ferroptosis17–19.
Recent studies revealed that ferroptosis is involved in
tubular cell death during acute kidney injury (AKI)18,20.
Ferrostatin-1 (Fer-1), a small-molecule compound that
inhibits lipid oxidation and subsequently suppresses fer-
roptosis, has been shown to abrogate tubular injury in
experimental AKI models21,22. In addition, tubular cell
death and interstitial edema within the kidney and pro-
teinuria were significantly increased in GPX4-null mice,
suggesting a reno-protective role for GPX4 in tubular
cells23. In contrast to AKI, however, the impact of fer-
roptosis on the development of diabetic nephropathy has
not been elucidated.
Therefore, the aim of the current study was to investi-
gate the role of ferroptosis in tubular cell death under
diabetic conditions. To test our hypothesis, we used TGF-
β-stimulated cultured kidney tubular cells and diabetic
mice models for in vitro and in vivo experiments,
respectively. Furthermore, we also examined the effect of
ferroptosis inhibition on diabetes-induced tubular cell
injury.
Materials and methods
Human kidney sample collection
Kidney biopsy samples were obtained from 44 adult
patients who underwent biopsy procedures due to medi-
cal indications at Yonsei Medical Center, Seoul, Korea.
Renal biopsy was performed in the standard manner24.
Microdissection of the kidney biopsy samples were per-
formed, as previously described25. Kidney tubules, with
glomeruli removal through microdissection, was stored in
RNAiso reagent at −70 °C (Takara Bio Inc., Otsu, Shiga,
Japan). Samples from type 2 diabetic patients whose kid-
ney biopsy pathological diagnosis revealed diabetic
nephropathy were allocated as diabetes mellitus (DM).
Non-DM samples were from those without DM and
whose pathological findings did not show specific
abnormalities or only minimal glomerular change. Kidney
tissues were collected with the approval from the Insti-
tutional Review Board for human research at Yonsei
University College of Medicine and informed consent was
obtained from all patients (4-2006-0154).
Cell culture and treatment of NRK-52E cells
NRK-52E cells, immortalized rat proximal tubular epi-
thelial cells, were maintained in DMEM supplemented
with 5% fetal bovine serum (FBS), 100 U/ml penicillin,
100mg/ml streptomycin, and 26mM NaHCO3, and were
grown at 37 °C in humidified 5% CO2 in air. The medium
was changed to DMEM containing 5.6 mM glucose 48 h
after seeding. Subconfluent NRK-52E cells were FBS-
restricted for 24 h, then the medium was replaced with 1%
FBS DMEM for the control group and the same medium
plus TGF-β1 (10 ng/ml; R&D Systems, Minneapolis, MN,
USA) for the TGF-β1 group. Both groups were treated
with Fer-1 (1–100 μM; Selleckchem, Houston, TX, USA).
NRK-52E cells were harvested 12 h after treatment. Cells
were stimulated with Erastin (Selleckchem) for positive
control ferroptosis induction.
Animal experiments
All animal protocols were approved by the Committee
for the Care and Use of Laboratory Animals at Yonsei
University College of Medicine in Seoul, Korea. All
experiments were conducted in accordance with the
Principles of Laboratory Animal Care (NIH Publication
no. 85-23, revised 1985). Forty C57BL/6 mice weighing
20–25 g were injected with either diluent [n= 20, control
(Con)] or 50mg/kg streptozotocin (STZ; Sigma-Aldrich,
St. Louis, MO, USA; n= 20, STZ) intraperitoneally for
five consecutive days. Tail vein blood glucose levels were
measured to confirm DM (fasting blood glucose >
300mg/dl). Ten mice from each group were treated with
Fer-1 (5 mg/kg/day) via Alzet osmotic pumps (DURECT
Corporation, Cupertino, CA, USA). Mice were housed in
a temperature-controlled room and given free access to
water and standard laboratory chow during the 12-week
study period. After 12 weeks, mice were anesthetized with
Zoletil (10 mg/kg; Virbac, Carros, France), and kidneys
were extracted after sacrifice. Body weight, kidney weight,
blood glucose, blood urea nitrogen (BUN), serum creati-
nine, 24-h urinary albumin, and creatinine concentrations
were determined at the time of sacrifice. Blood glucose
was measured with a glucometer, and 24-h urinary albu-
min was assessed via enzyme-linked immunosorbent
assay (ELISA; Nephrat II, Exocell Inc., Philadelphia, PA,
USA). BUN, serum creatinine, and 24-h urinary creatinine
were analyzed using a Cobas 8000 C702 (Roche, Man-
nheim, Baden Württemberg, Germany). Type 2 DM db/
dbmice and genetic control non-DM db/m mice (6 weeks
old, three per group) were obtained from Jackson
Laboratories (Bar Harbor, ME, USA) and were sacrificed
after 12 weeks.
Quantitative real-time polymerase chain reaction
Total RNA purification, reverse transcription, and real-
time polymerase chain reaction (PCR) of renal biopsy
samples, NRK-52E cells, and whole kidney samples were
performed, as previously described26. A total reaction
volume of 20 μl per well was used, including 25 ng RNA
and 10 μl SYBR Green PCR Master Mix (Applied
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Biosystems). PCR conditions consisted of initial heating
for 9 min at 95 °C, followed by 40 cycles of denaturation
for 30 s at 94.5 °C, annealing for 30 s at 60 °C, and
extension for 1 min at 72 °C, and a final extension for
7 min at 72 °C. PCR was performed using an ABI PRISM
7700 Sequence Detection System (Applied Biosystems,
Foster City, CA, USA). Primer sequences used for real-
time PCR were: Slc7a11 (human), forward 5′-CCCAGA
TATGCATCGTCCTT-3′ reverse 5′-CCTGGGTTTCTT
GTCCCATA-3′; Slc7a11 (rat), forward 5′-TGAATGCCT
TGTCTGCTTTG-3′ reverse 5′-GAATTGCAGGGAACT
GTGGT-3′; Slc7a11 (mouse), forward 5′-GATGCTGTG
CTTGGTCTTGA-3′ reverse 5′-GCCTACCATGAGCAG
CTTTC-3′; Gpx4 (human), forward 5′-AGATCCAC
GAATGTCCCAAG-3′ reverse 5′-CCTCCTCCTTAAAC
GCACAC-3′; Gpx4 (rat, mouse), forward 5′-CCGGCTA
CAATGTCAGGTTT-3′ reverse 5′-ACGCAGCCGTTCT
TATCAAT-3′; Fth1 (rat), forward 5′-ATGATGTGGCCC
TGAAGAAC-3′ reverse 5′-TCATCACGGTCAGGTTTC
TG-3′; Fth1 (mouse), forward 5′-GCCGAGAAACTGAT
GAAGCTGC-3′ reverse 5′-GCACACTCCATTGCATTC
AGCC-3′; 18 s (human), forward 5′-ACCGCGGTTCTAT
TTTGTT-3′ reverse 5′-CGGTCCAAGAATTTCACCTC-
3′; 18 s (rat), forward 5′-CAAGTAGGAGAGGAGCGAG
C-3′ reverse 5′-CATGTCTAAGTACGCACGGC-3′; 18 s
(mouse), forward 5′-CGCTTCCTTACCTGGTTGAT-3′
reverse 5′-GGCCGTGCGTACTTAGACAT-3′.
cDNA content of each specimen was determined using
a comparative CT method with 2
−△△CT. Results are
shown as relative expression normalized to 18 s rRNA
expression with arbitrary units.
Western blot analysis
Western blotting was performed as previously descri-
bed26. Primary antibodies were polyclonal antibodies to
xCT (NB300-318, Novus Biologicals, Littleton, CO, USA),
GPX4 (NBP2-75511, Novus Biologicals), ferritin heavy
chain 1 (FTH1, #3998, Cell Signaling Technology, Dan-
vers, MA, USA), p53 (#9282 S, Cell Signaling Technol-
ogy), NRF2 (NBP1-32822, Novus Biologicals), β-actin
(A5441, Sigma-Aldrich), or Lamin B1 (ab133741, Abcam).
Membranes were washed three times for 10min in TBS
with 0.1% Tween-20 then incubated in buffer A con-
taining a 1:1000 dilution of horseradish peroxidase-
conjugated goat-anti rabbit, or anti-mouse IgG (GenDE-
POT, Barker, TX). ImageJ software (NIH, Bethesda, MD,
USA) was used to measure band intensities, and changes
in treated groups relative to control cells or tissues were
used for analysis.
Cell viability assay
Cell viability was assessed using a 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay
kit (Thermo Fisher Scientific, Waltham, MA, USA).
NRK-52E cells were seeded onto 96-well plates (3 × 103
per well) and FBS-restricted for 24 h. Subsequently, cells
were treated with various concentrations of TGF-β1 or
Fer-1. Cell viability was determined at different time
points after treatment (usually 12 h, unless stated other-
wise). Fresh medium containing 0.5 mg/ml MTT solution
was added to each well and incubated for 4 h at 37 °C. The
supernatant was aspirated, and 100 μl DMSO (Sigma-
Aldrich) was added. Absorbance was measured at 570 nm
using a VersaMax ELISA Microplate Reader (Molecular
Devices, Silicon Valley, CA, USA).
Iron assay
Intracellular and tissue levels of total iron were
assessed using an iron assay kit (Sigma-Aldrich). Cul-
tured cells (1 × 106 cells) or mouse kidney tissue sam-
ples (10 mg) were harvested and homogenized in iron
assay buffer. All samples were centrifuged at 16,000 × g
for 10 min. A total of 10 μl of supernatant from each
sample was added to 90 μl of the iron assay buffer.
Subsequently, 5 μl of iron reducer was added to each
supernatant. The mixture was incubated for 30 min,
and total iron levels were determined using iron probe
at a wavelength of 593 nm.
Glutathione assay
Glutathione concentration was assessed using a Glu-
tathione Assay Kit (Sigma-Aldrich). Cultured cells and
mouse kidneys were harvested and lysed by repeated
freeze–thaw cycles in 5% 5-sulfosalicylic acid solution and
centrifuged at 10,000 r.p.m. for 10min. A total of 10 μl of
supernatant from each sample was added to 150 μl of the
working mixture (glutathione reductase and DTNB
solution) and incubated for 5 min at RT. NADPH solution
was added to each well, and glutathione levels were
determined by kinetic absorbance measurement (1 min
intervals for 5 min) at a wavelength of 412 nm. The glu-
tathione content of each specimen was calculated by
comparison with the standard.
Measurement of lipid peroxidation
Lipid peroxidation (malondialdehyde, MDA) was
assessed using a lipid peroxidation assay kit (Abcam,
Cambridge, United Kingdom) and an Image-iT® Lipid
Peroxidation Kit (Thermo Fisher Scientific) for live cells.
For the MDA assay, cultured cells and whole mouse
kidneys were harvested and lysed in lysis solution (MDA
lysis buffer and 5% butylated hydroxytoluene) then cen-
trifuged at 13,000 r.p.m. for 10 min at 4 °C. Supernatants
were removed, and MDA levels were determined using
the reaction of thiobarbituric acid at a wavelength of
532 nm. The MDA content of each specimen was calcu-
lated by comparison with the standard. For the Image-iT®
lipid peroxidation analysis, cells were seeded onto
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two-well chamber slides (2 × 104 per well) and treated
with TGF-β1 or Fer-1, after 24 h. The Image-iT® lipid
peroxidation sensor was added to each well and incubated
for 30min at 37 °C. Supernatants were removed, and
samples were washed three times with PBS. Images were
analyzed using an LSM700 confocal microscope (Carl Zeiss
Vision, Hallbergmoos, Germany) under ×40 magnification.
Flow cytometry with C11-BODIPY probe
In order to assess the lipid peroxidation accumulation,
fluorescence-activated cell sorting (FACS) was used with
C11-BODIPY probe. NRK-52E cells were seeded in six-
well plates. After TGF-β1 stimulated for 12 h, cells were
stained with C11-BODIPY (581/591) at 37 °C for 30min.
After washing and resuspension in FACS buffer (PBS with
5% FBS), stained cells were analyzed with LSRII using
FACS Diva software (BD Bioscience, San Jose, CA, USA)
and analyzed using FlowJo software, version 10.2
(TreeStar, San Carlos, CA, USA).
Transmission electron microscopy
TGF-β1 or Erastin-stimulated NRK-52E cells with or
without Fer-1 treatment were fixed for 12 h in 2% glu-
taraldehyde (Merck Millipore, Darmstadt, Germany)–2%
paraformaldehyde (Merck Millipore) in 0.1M phosphate
buffer (pH 7.4) and washed in 0.1M phosphate buffer,
postfixed with 1% OsO4 (Polysciences) in 0.1M phos-
phate buffer for 2 h and dehydrated with an ascending
ethanol series. Cells were then embedded, mounted, and
stained with toluidine blue for optical microscope obser-
vation. Images were captured with a transmission electron
microscopy (JEOL, Tokyo, Japan) with a Megaview III
CCD camera (Soft imaging system, Germany).
Immunohistochemistry
Kidney samples were fixed in 10% neutral-buffered
formalin and processed to 5 μm thick sections for
immunohistochemistry. Tissue sections were depar-
affinized, rehydrated in ethyl alcohol, and washed in tap
water. Antigen retrieval was performed using 10mM
sodium citrate buffer for 20min in a Black & Decker
vegetable steamer. Slides were blocked with 10% donkey
serum for 30min at RT, and then washed with PBS. Pri-
mary antibodies against xCT (Novus Biologicals), GPX4
(Novus Biologicals), 4-hydroxynonenal (4-HNE; ab46545,
Abcam), or MDA (ab6463, Abcam) were diluted to the
appropriate concentration with 2% casein in bovine serum
albumin, added to the slides, and incubated overnight at
4 °C. After washing, the secondary antibody (Dako, Car-
pinteria, CA, USA) was applied for 1 h at RT. Diamino-
benzidine was added for 2 min, and sections were
counterstained with hematoxylin. A semiquantitative
score for staining intensity was obtained by examining at
least five fields per section under ×20 magnification and
with digital image analysis (MetaMorph version 4.6r5,
Universal Imaging Corp., Downingtown, PA, USA).
Terminal deoxynucleotidyl transferase dUTP nick-end
labeling assay
Cell death was evaluated using a terminal deox-
ynucleotidyl transferase dUTP nick-end labeling
(TUNEL) assay with a commercially available kit (Merck
Millipore, Darmstadt, Germany). TUNEL-positive tubular
cells were identified in formalin-fixed kidney tissue by
examining at least 15 regions at ×20 magnification. Data
are expressed as the number of positively stained nuclei
(indicating apoptotic cells) per field.
NE-PER nuclear and cytoplasmic extraction
Cells and kidney tissue samples were collected, cut into
small pieces, washed with PBS, and then homogenized
with beads in certain volume of cytoplasmic extraction
reagent (CER) I in NE-PER Nuclear and Cytoplasmic
Extraction Reagents kit (ThermoFisher, Waltham, MA)
according to the weight of kidneys. After 15 s of vigorous
vortexing and 10min of incubation on ice, CER II was
added to each kidney samples followed by incubation on
ice for 1 min and centrifugation at 16,000 × g for 5 min.
The supernatant was collected as cytoplasmic extract, and
the insoluble fraction was suspended in nuclear extraction
reagent. After 10 min of centrifugation at 16,000 × g, each
supernatant was collected and used as nuclear extract.
Statistical analysis
All data are representative at least three independent
experiments. Data are expressed as mean ± standard
deviation (SD). Statistical differences were analyzed using
t test and one-way ANOVA with Bonferroni post hoc test
using Prism 5 (GraphPad, San Diego, CA). A P value
< 0.05 was considered statistically significant.
Results
Slc7a11 and Gpx4 expression was decreased in diabetic
patient kidney tubules
The baseline characteristics of the patients are shown in
Table 1. The median age of the control and diabetic
patients was 25 (18–55) and 52 (24–74) years, respec-
tively. The mean DM duration of the patients was 10.96
(1–25) years, and 23 (82.1%) subjects had hypertension,
whereas none tof the subjects without DM had HTN.
When comparing subjects with and without DM, those
with DM tended to have higher serum creatinine levels,
higher serum BUN levels, and a higher UPCR. We
assessed changes in ferroptosis-related molecules, such as
xCT (Slc7a11) and GPX4 (Gpx4) in kidney biopsy samples
from all study subjects. Kidney tubular Slc7a11 and Gpx4
mRNA expression was significantly lower in patients with
DM than in non-DM patients (P < 0.001; Fig. 1A, B).
Kim et al. Cell Death and Disease          (2021) 12:160 Page 4 of 14
Official journal of the Cell Death Differentiation Association
These results suggest that ferroptosis is increased in
kidney tubules of diabetic patients.
Kidney tubular cell death due to TGF-β1 is associated with
upregulation of ferroptosis-related molecules
To explore cell death via ferroptosis in kidney cells, we
analyzed NRK-52E cells with or without TGF-β1 (10 ng/ml)
treatment. A cell viability assay revealed that cell death was
significantly increased in TGF-β1-stimulated cells compared
to control cells in a time-dependent manner (P < 0.05 for
12 h, P < 0.001 for 24 h; Fig. 2A). Next, we measured xCT
and GPX4 expression, and found that TGF-β1 stimulation
significantly reduced the expression of Slc7a11 (P < 0.001,
Fig. 2B) and Gpx4 mRNA (P < 0.01 for 12 h, P < 0.001 for
24 h; Fig. 2B). Expression of xCT (P < 0.001 for 12 h, P < 0.01
for 24 h; Fig. 2C) and GPX4 (P < 0.001 for 6 h, P < 0.01 for 12
and 24 h; Fig. 2C) protein was also decreased in TGF-β1-
stimulated cells. In addition, glutathione concentration was
significantly decreased in NRK-52E cells exposed to TGF-β1
(P < 0.05 for 12 h, P < 0.01 for 24 h; Fig. 2D), whereas lipid
peroxidation was significantly increased (P < 0.001 for 6, 12,
and 24 h; Fig. 2E). Similar effects were observed with lipid
peroxidation staining (Fig. 2F). Comparable findings were
observed in Erastin-stimulated NRK-52E cells (Supplemen-
tary Fig. 1A–E). These results suggest that TGF-β1 reduces
not only the influx of cysteine, which in turn diminishes
glutathione synthesis, but also causes the degradation of
lipid peroxide in TGF-β1-stimulated NRK-52E cells in a
time-dependent manner. Both of these changes result in an
accumulation of intracellular lipid peroxide, which ulti-
mately leads to ferroptosis-induced cell death.
Ferroptosis inhibitors abrogates TGF-β1-induced kidney
tubular cell death
Next, we investigated the impact of Fer-1, an inhibitor
of the ferroptosis pathway, on TGF-β1-induced kidney
tubular cell death. Administration of Fer-1 (100 µM) sig-
nificantly ameliorated the decrease in the viability of TGF-
β1-stimulated NRK-52E cells (P < 0.001; Fig. 3A).
Expression of Slc7a11 (P < 0.001, Fig. 3B) and Gpx4 (P <
Table 1 Clinical parameters.
Non-DM (n= 16) DM (n= 28)
Sex, n (%)
Men 14 (87.50) 17 (60.71)
Women 2 (12.50) 11 (39.29)
Age, years 25.00 ± 11.60 52.32 ± 12.05
BMI, kg/m2 22.03 ± 3.08 24.94 ± 4.28
HTN, n (%) 0.0 (0) 23 (82.14)
DM duration, years — 10.96 ± 7.47
Serum creatinine, mg/dl 0.89 ± 0.12 2.62 ± 1.78
Serum BUN, mg/dl 13.09 ± 3.41 33.06 ± 14.05
eGFR, ml/min/1.73 m2 114.13 ± 18.19 40.71 ± 30.46
UPCR, g/g cr 0.29 ± 0.35 8.06 ± 5.68
Data are shown as mean ± standard deviation.
BMI body mass index, HTN hypertension, DM diabetes mellitus, BUN blood urea
nitrogen, eGFR estimated glomerular filtration rate, UPCR urine protein to
creatinine ratio.
Fig. 1 Expression of ferroptosis-related molecules Slc7a11 and Gpx4 was decreased in diabetic nephropathy of kidney biopsy tissues. A, B
Slc7a11 and Gpx4 mRNA expression was significantly decreased in the DM group compared to the non-DM group. Bonferroni t tests were used for
statistical analysis. Error bars represent SD. ***P < 0.001 versus non-DM group; non-DM group, n= 17; DM group, n= 28.
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Fig. 2 TGF-β1 induces kidney tubular cell death along with changes in ferroptosis-related molecules. A Cell viability measured via an MTT
assay revealed a significant increase in the death of cultured NRK-52E cells exposed to TGF-β1 (10 ng/ml) in a time-dependent manner. B TGF-β1
caused a marked decrease in mRNA expression of ferroptosis-related molecules Slc7a11 and Gpx4 in NRK-52E cells. C Expression of xCT and GPX4
protein was significantly decreased in TGF-β1-stimulated NRK-52E cells compared to control cells. D Glutathione concentration was significantly
decreased in cultured NRK-52E cells exposed TGF-β1 (10 ng/ml) after 6, 12, and 24 h. E TGF-β1 significantly induced lipid peroxidation in NRK-52E
cells after 6, 12, and 24 h. F Lipid peroxidation assessed using image-iT® revealed an increase in TGF-β1-treated NRK-52E cells after 12 h. As shown is
representative of three independent replicates. One-way ANOVA and Bonferroni post hoc tests were used for statistical analysis. Error bars represent
SD. Original magnification, ×40 for all. Scale bar= 20 µm. *P < 0.05; ***P < 0.001 versus 0 h group.
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Fig. 3 Effect of Fer-1 treatment on cell viability and changes in ferroptosis-related molecules in TGF-β1-stimulated NRK-52E cells at 12 h.
A MTT assay revealed that administration of Fer-1 (100 µM) significantly abrogated the decrease in cell viability in cultured NRK-52E cells exposed to
TGF-β1 (10 ng/ml). B The decrease in Slc7a11 and Gpx4 mRNA expression seen in TGF-β1-stimulated NRK-52E cells was significantly ameliorated after
Fer-1 treatment. C The decrease in xCT and GPX4 protein expression seen in TGF-β1-stimulated NRK-52E cells was significantly attenuated after Fer-1
treatment. D The increase in total iron levels in TGF-β1-stimulated NRK-52E cells was significantly abrogated after Fer-1 treatment. E The increase in
protein and mRNA expression levels of FTH1 in TGF-β1-stimulated NRK-52E cells was significantly attenuated after Fer-1 treatment. F Transmission
electron microscope images of mitochondria. Red arrow indicates mitochondria cristae vanish. Blue arrowhead indicates outer mitochondria
membrane rupture. As shown is representative of three independent replicates. One-way ANOVA and Bonferroni post hoc tests were used for
statistical analysis. Error bars represent SD. Original magnification, ×150 for upper and ×600 for lower. Scale bar= 2000 µm (upper), 500 µm (lower).
**P < 0.01; ***P < 0.001 versus Con group. #P < 0.05; ##P < 0.01; ###P < 0.001 versus TGF-β1 group.
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0.05, Fig. 3B) mRNA was significantly attenuated by Fer-1
in TGF-β1-stimulated NRK-52E cells. In addition, the
expression of xCT (P < 0.01, Fig. 3C) and GPX4 (P < 0.001,
Fig. 3C) protein was also significantly abrogated by Fer-1
administration NRK-52E cells. Furthermore, total iron
levels and mRNA and protein levels of FTH1 was sig-
nificantly increased in TGF-β1-treated NRK-52E cells
compared to controls (Figs. 3D, E). The increase in total
iron level, and FTH1 expression level was abrogated with
Fer-1 treatment. A similar finding was noted in NRK-52E
cells stimulated with the ferroptosis inducing positive
control Erastin (Supplementary Fig. 2A–E). When the
mitochondria morphologic features were observed
through TEM, TGF-β1-treated NRK-52E cells revealed
features of mitochondria shrinkage and vanishing of
mitochondrial cristae. These findings were comparable to
the Erastin-induced positive control ferroptosis morpho-
logic features. These noted changes of the mitochondria
were attenuated with the Fer-1 treatment (Fig. 3F).
The decrease in glutathione concentration caused by
TGF-β1 was ameliorated by Fer-1 treatment (P < 0.05
versus Fer-1 10 µM, P < 0.001 versuss Fer-1 100 µM; Fig. 4A).
Lipid peroxidation was attenuated by administration of
Fer-1 100 µM (P < 0.001; Figs. 4B–D). In addition, Fer-1
abrogated lipid peroxidation in Erastin-stimulated NRK-
52E cells (Supplementary Fig. 3A–C). Taken together,
these findings suggest that ferroptosis is involved in TGF-
β1-induced tubular cell death.
Fer-1 protects against kidney injury in an experimental
model of diabetes
In the animal experiments, body weight was sig-
nificantly lower in the STZ-induced diabetic group
(22.33 ± 1.73 g) than the Con group (30.32 ± 3.61 g; P <
0.001; Table 2), and this was improved following treat-
ment with Fer-1 (26.81 ± 2.71 g; P < 0.001; Table 2), at the
end of the 12-week study period. In contrast, kidney
weight and the ratio of kidney weight to body weight were
significantly higher in the STZ group than the Con group
(P < 0.05 for kidney weight, P < 0.001 for kidney/body
weight; Table 2), and again, these effects were rescued by
administration of Fer-1 (P < 0.05 for kidney weight, P <
0.001 for kidney/body weight; Table 2). Mean blood glu-
cose levels were significantly higher in the STZ (524.00 ±
84.18 mg/dl) and STZ+ Fer-1 (515.70 ± 94.51 mg/dl)
groups than the Con group (126.20 ± 17.50 mg/dl; P <
0.001; Table 2). Moreover, the ratio of urinary albumin to
creatinine was significantly higher in the STZ group
(0.053 ± 0.017 µg/mg) than the Con group (0.015 ±
0.004 µg/mg; P < 0.001; Table 2), and this was attenuated
by Fer-1 treatment (0.033 ± 0.010 µg/mg; P < 0.05; Table
2). The elevated serum BUN and creatinine levels in the
STZ group, compared to the Con group, showed ten-
dencies of attenuation in the STZ+ Fer-1 group (Table 2).
Next, we sought to determine whether ferroptosis was
induced in the kidneys of the experimental diabetic ani-
mals and whether Fer-1 could mitigate the kidney injury
induced by DM. The expression of xCT and GPX4 was
significantly lower (P < 0.001 for Slc7a11, xCT, and GPX4;
P < 0.01 for Gpx4; Fig. 5A–C), while cell death, assessed
by a TUNEL assay, was significantly higher in the kidneys
of STZ mice (P < 0.001; Fig. 5C) than in the kidneys of
Con mice. The effects on xCT (Slc7a11) and GPX4
(Gpx4) expression, as well as cell death were all sig-
nificantly improved following Fer-1-treatment (P < 0.05;
Fig. 5A–C). In addition, total iron level and mRNA and
protein levels of FTH1 was significantly increased in the
kidneys of STZ and db/db mice compared to control and
db/m mice, respectively (Figs. 5D–F).
Kidney glutathione concentration was significantly
decreased (P < 0.001; Fig. 6A), whereas lipid peroxidation
was significantly increased (P < 0.001; Fig. 6B) in the
kidneys of animals in the STZ group, and these changes
were ameliorated following administration of Fer-1 (P <
0.05 for glutathione concentration, P < 0.01 for lipid per-
oxidation; Fig. 6A, B). Also, MDA and 4-HNE, lipid per-
oxidation markers, were significantly attenuated after Fer-
1-treatment (P < 0.001 for MDA, P < 0.05 for 4-HNE; Fig.
6C). The decrease in glutathione concentration and
increase in lipid peroxidation was also observed in the
kidneys of db/db when compared to db/m mice (Figs. 6A,
B). Together, these findings demonstrate that ferroptosis
is induced in experimental diabetic nephropathy through
the effect of TGF-β1 and that treatment with Fer-1, a
ferroptosis inhibitor, attenuated kidney cell death in dia-
betic mice (Fig. 6D).
Tubular expression of NRF2 and p53 in diabetic
nephropathy
In order to assess the relationship between ferroptosis
and NRF2 and p53, the expression levels of NRF2 and p53
were further evaluated. The p53 and nuclear NRF2 pro-
tein and levels were significantly increased in TGF-β1-
stimulated NRK-52E cells than control cells (Supple-
mentary Fig. 4A). These findings were comparable to the
Erastin-induced positive control ferroptosis features
(Supplementary Fig. 4B). A similar increase in p53 and
nuclear NRF2 protein levels were also noted in the kid-
neys of STZ and db/db mice compared to control and db/
m mice (Supplementary Fig. 4C, D).
Discussion
In the present study, we found that Slc7a11 and Gpx4
mRNA expression was lower in DM patients than non-
DM patients. We also demonstrated that xCT and GPX4
expression was significantly lower in cultured tubular
epithelial cells that were exposed to TGF-β1, as well as in
the kidneys of diabetic mice, resulting in low glutathione
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levels and enhanced lipid peroxidation. Moreover,
administration of the ferroptosis inhibitor, Fer-1, sig-
nificantly abrogated not only the changes in glutathione
levels and lipid peroxidation, but also cell death in TGF-
β1-stimulated cultured tubular cells. Fer-1 also sig-
nificantly ameliorated kidney hypertrophy and
albuminuria, and reduced intrarenal accumulation of lipid
peroxidation in the diabetic mice.
In diabetic nephropathy, kidney dysfunction accom-
panied by nephron loss has been attributed to inflam-
mation, ECM accumulation, and tubular cell death, which
is also seen in nephrotoxic and ischemia-reperfusion
Fig. 4 Ferroptosis inhibitors attenuated glutathione concentration and lipid peroxidation in TGF-β1-stimulated NRK-52E cells after 12 h.
A The decrease in glutathione concentration seen in cultured NRK-52E cells exposed TGF-β1 (10 ng/ml) was significantly ameliorated by Fer-1 (10
and 100 µM) treatment. B Administration of Fer-1 significantly attenuated the increase in lipid peroxidation seen in TGF-β1-stimulated NRK-52E cells.
C FACS evaluated BODIPY 581/591-C11 fluorescence intensity. D Lipid peroxidation assessed using Image-iT® revealed that the increase seen in
cultured NRK-52E cells after exposure to TGF-β1 was significantly abrogated by Fer-1 treatment. As shown is representative of three independent
replicates. One-way ANOVA and Bonferroni post hoc tests were used for statistical analysis. Error bars represent SD. Original magnification, ×40 for all.
Scale bar= 20 µm. ***P < 0.001 versus Con group. #P < 0.05; ##P < 0.01; ###P < 0.001 versus TGF-β1 group.
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injury models27,28. Meanwhile, since the proximal tubule
requires high energy and relies on aerobic metabolism, a
consequence of increased consumption, impaired utili-
zation, and reduced delivery of O2, makes it vulnerable to
ischemic injury in diabetes29. Therefore, tubular cell death
has been recognized as one of the key findings in kidney
damage of various etiologies. In particular, in addition to
apoptosis, recent reports have shown regulated necrosis
to play a role in the pathogenesis of AKI30. Based on these
findings, the possibility of regulated necrosis, including
necroptosis, pyroptosis, and ferroptosis, to contribute in
diabetes-associated tubular cell has been proposed.
However, most of the previous studies on tubular cell
death under diabetic conditions have only addressed
apoptotic cell death14,15,31.
Ferroptosis is a form of regulated cell death character-
ized by the iron-dependent accumulation of lipid hydro-
peroxides such that they reach lethal levels. It was first
described by Dixon et al. as a type of cell death induced by
the small-molecule Erastin, which inhibits xCT16. xCT
imports cystine into cells, where it is further reduced to
cysteine32. Cysteine in subsequently converted to glu-
tathione by the addition of glutamate and glycine33.
Glutathione is essential for the function of GPX4, which
converts potentially toxic lipid hydroperoxides to non-
toxic lipid alcohols and as a result, prevents the accu-
mulation of lipid reactive oxygen species34. Therefore, a
decrease in xCT inhibits the intracellular import of
cysteine, leading to less glutathione synthesis, lower GPX4
activity, and ultimately the accumulation of lipid hydro-
peroxides, which is linked to loss of plasma membrane
integrity35. To date, only a limited number of studies have
investigated changes in xCT and GPX4 expression under
diabetic conditions. Carpi-Santos et al. found that xCT
subunit protein expression is significantly decreased in
high glucose-stimulated cultured retinal cells and retinas
of STZ-induced diabetic rats, and this is accompanied by
lower glutathione levels and an increase in oxidative
stress36. Furthermore, a recent study showed that patients
with diabetes exhibit significantly lower levels of GPX4
enzyme in their heart, than age-matched nondiabetic
patients37. In accordance with results from previous stu-
dies, we demonstrated that xCT and GPX4 mRNA and
protein expression, both of which are key molecules
involved in ferroptosis, were significantly decreased in
cultured tubular epithelial cells exposed to TGF-β1 and in
the kidneys of STZ mice, suggesting that these changes
may contribute to the decrease in glutathione con-
centration and the increase in lipid peroxidation.
The manifestations of diabetic nephropathy are known
to be a consequence of the actions of certain cytokines
and growth factors. Of these, TGF-β1 is considered as the
key player of diabetic nephropathy development in both
type 1 and type 2 DM38. The high glucose stimulation in
diabetic conditions increase TGF-β1 expression in kidney
cells, which promotes cellular hypertrophy and matrix
production39. Accordingly, TGF-β1 stimulation has been
widely used as an effective diabetic nephropathy in vitro
model. The results found with TGF-β1 stimulation in this
study were comparable to the features found in kidney
tubular cells treated with the positive control ferroptosis
inducer Erastin, suggesting that ferroptosis may be
induced in kidney tubular cells under diabetic conditions.
These results are in line with a recent investigation which
has shown that TGF-β1 represses xCT expression via
Smad3 activation, and enhances lipid peroxidation in
hepatocellular carcinoma cells40. Since TGF-β1 is known
to increase reactive oxygen species production41, the
accumulation of oxidative stress through TGF-
β1 stimulation may lead to ferroptosis development. In
addition, there could also be a possibility in which TGF-
β1 directly inhibits the cystine/glutamate antiporter xCT.
However, further evaluations would be needed to eluci-
date the precise mechanism.
To date, a number of studies have suggested that fer-
roptosis plays a pathological role in the development of
Table 2 Kidney function parameters in animal model.
Con Con+ Fer-1 STZ STZ+ Fer-1
Body weight, g 30.32 ± 3.61 29.33 ± 1.54 22.33 ± 1.73 26.81 ± 2.71
Kidney weight, mg 188.40 ± 12.23 177.55 ± 7.65 197.05 ± 14.41 186.10 ± 11.49
Kidney/body weight, 10−3 6.28 ± 0.62 6.07 ± 0.43 8.84 ± 0.40 6.98 ± 0.46
Blood glucose, mg/dl 126.20 ± 17.50 114.70 ± 18.87 524.00 ± 84.18 515.70 ± 94.51
Serum creatinine, mg/dl 0.15 ± 0.04 0.13 ± 0.02 0.24 ± 0.09 0.20 ± 0.04
Serum BUN, mg/dl 24.92 ± 2.42 23.00 ± 1.17 29.26 ± 2.80 26.90 ± 4.12
UACR, µg/mg 0.015 ± 0.004 0.013 ± 0.001 0.053 ± 0.017 0.033 ± 0.010
Data are shown as mean ± standard deviation.
Con control, Fer-1 ferrostatin-1, DM diabetes mellitus, BUN blood urea nitrogen, UACR urine albumin to creatinine ratio.
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Fig. 5 Effect of Fer-1 on cell viability and changes in ferroptosis-related molecules in the kidney of diabetic mice. A Kidney Slc7a11 and Gpx4
mRNA expression was significantly lower in STZ mice than the Con group, and changes in the STZ kidney were abrogated by Fer-1 treatment. B xCT
and GPX4 protein expression assessed by western blot was significantly lower in the STZ kidney, and this was ameliorated by administration of Fer-1.
C TUNEL staining showed a significant increase in cell death in the STZ kidney, which was alleviated by Fer-1 treatment. D Protein and mRNA
expression of xCT and GPX4 in kidney samples of db/db mice. E Total iron levels measured in kidney samples of STZ and db/db mice. F Protein and
mRNA expression level of FTH1 in kidney samples of STZ and db/db mice. One-way ANOVA and Bonferroni post hoc tests were used for statistical
analysis. Error bars represent SD. Original magnification, ×20 for all. Scale bar= 100 µm. **P < 0.01; ***P < 0.001 versus Con group. #P < 0.05; ##P < 0.01;
###P < 0.001 versus STZ group. n= 10 for each group of STZ. n= 3 for each group of db/db.
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Fig. 6 Effect of Fer-1 on glutathione concentration and lipid peroxidation in the kidney of diabetic mice. A Glutathione concentration in the
kidneys of STZ and db/dbmice. B Lipid peroxidation assessed by MDA levels in the kidneys of STZ and db/dbmice. C Immunohistochemistry for MDA
and 4-HNE was significantly increased in the STZ group, and this was abrogated by administration of Fer-1. D Schematic diagram of TGF-β1-induced
ferroptosis in diabetic nephropathy. One-way ANOVA and Bonferroni post hoc tests were used for statistical analysis. Error bars represent SD. Original
magnification, ×20 for all. Scale bar= 100 µm. *P < 0.05; ***P < 0.001 versus Con group. #P < 0.05; ##P < 0.01 versus STZ group; ROS reactive oxygen
species. n= 10 for each group of STZ. n= 3 for each group of db/db.
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degenerative brain disorders, including Parkinson’s42,
Huntington’s43,44, and Alzheimer’s disease45,46, as well as
in diverse types of cancer47,48 and AKI21–23. Furthermore,
ferroptosis inhibitors such as Fer-1, which is a novel
potent first generation small molecule, inhibit ferroptosis
by blocking lipid peroxidation and thus ameliorate
pathologic abnormalities in various diseases. In addition, a
novel third-generation ferrostatin (termed 16–86) was
recently generated and was shown to be more stable and
potent than the first-in-class compound Fer-1 (ref. 22). In
the present study, when Fer-1 was used to inhibit fer-
roptosis TGF-β1-induced tubular cell death was atte-
nuated and lipid peroxidation was reduced, suggesting
that ferroptosis may play a role in the development of
diabetic tubulopathy. Cell death within kidney tissue was
assessed via TUNEL staining in the current study, which
has been widely used to examine in vivo cell death in
various tissues49–52. Since double-strand breaks are found
in most cells undergoing programmed cell death, the
majority of cells will be positive for TUNEL staining53.
However, a TUNEL-positive signal is not limited to
apoptotic cells, and cells that have undergone regulated
necrosis will also be TUNEL positive54. One way to dif-
ferentiate apoptosis from regulated necrosis is to perform
immunohistochemical staining for cleaved caspase-3 in
addition to TUNEL staining; however, this was not done
in the present study.
Tubular atrophy and tubulointerstitial fibrosis are the
main pathological features associated with kidney dys-
function in patients with diabetic nephropathy55. Com-
pared to glomerular or vascular lesions, tubulointerstitial
lesions were found to be more useful for predicting renal
prognosis in DM patients56–58. Even though the under-
lying pathways that mediate the development of tubu-
lointerstitial lesions in diabetic nephropathy are not well
understood, previous studies have suggested that TGF-β1
is the principal mediator of the deleterious effects of the
diabetic milieu11. Furthermore, the impact of TGF-β1 on
oxidative stress, ECM synthesis, and cell viability is sig-
nificantly more powerful than that of high glucose7,59,60.
Thus, in the current study, we used normal glucose
medium plus TGF-β1 rather than high glucose medium
for the cell culture experiments.
In summary, the results of present study provide evi-
dence that glutathione levels are significantly decreased in
TGF-β1-stimulated kidney tubular cells and in the kid-
neys of diabetic mice, and this is accompanied by a sig-
nificant reduction in xCT and GPX4 expression and a
significant increase in lipid peroxidation. Furthermore,
these changes are associated with cell death under dia-
betic conditions, which is significantly ameliorated by
ferroptosis inhibition. These findings suggest that fer-
roptosis plays a significant role in the development of
diabetic nephropathy.
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